Hemodynamics(Redirected from Blood flow)
Hemodynamics or hæmodynamics is the dynamics of blood flow. The circulatory system is controlled by homeostatic mechanisms, much as hydraulic circuits are controlled by control systems. Hemodynamic response continuously monitors and adjusts to conditions in the body and its environment. Thus hemodynamics explains the physical laws that govern the flow of blood in the blood vessels.
Blood flow ensures the transportation of nutrients, hormones, metabolic wastes, O2 and CO2 throughout the body to maintain cell-level metabolism, the regulation of the pH, osmotic pressure and temperature of the whole body, and the protection from microbial and mechanical harms.
Blood is a non-Newtonian fluid, best studied using rheology rather than hydrodynamics. Blood vessels are not rigid tubes, so classic hydrodynamics and fluids mechanics based on the use of classical viscometers are not capable of explaining hemodynamics.
Blood is a complex liquid. Blood is composed of plasma and formed elements. The plasma contains 91.5% water, 7% proteins and 1.5% other solutes. The formed elements are platelets, white blood cells and red blood cells, the presence of these formed elements and their interaction with plasma molecules are the main reasons why blood differs so much from ideal Newtonian fluids.
Viscosity of plasmaEdit
Normal blood plasma behaves like a Newtonian fluid at physiological rates of shear. Typical values for the viscosity of normal human plasma at 37 °C is 1.4 mN·s/m2. The viscosity of normal plasma varies with temperature in the same way as does that of its solvent water; a 5 °C increase of temperature in the physiological range reduces plasma viscosity by about 10%.
Osmotic pressure of plasmaEdit
The osmotic pressure of solution is determined by the number of particles present and by the temperature. For example, a 1 molar solution of a substance contains ×1023 molecules per liter of that substance and at 0 °C it has an osmotic pressure of 2.27 MPa (22.4 atm). The osmotic pressure of the 6.022plasma affects the mechanics of the circulation in several ways. An alteration of the osmotic pressure difference across the membrane of a blood cell causes a shift of water and a change of cell volume. The changes in shape and flexibility affect the mechanical properties of whole blood. A change in plasma osmotic pressure alters the hematocrit, that is, the volume concentration of red cells in the whole blood by redistributing water between the intravascular and extravascular spaces. This in turn affects the mechanics of the whole blood.
Red blood cellsEdit
The red blood cell is highly flexible and biconcave in shape. Its membrane has a Young's modulus in the region of 106 Pa. Deformation in red blood cells is induced by shear stress. When a suspension is sheared, the red blood cells deform and spin because of the velocity gradient, with the rate of deformation and spin depending on the shear-rate and the concentration. This can influence the mechanics of the circulation and may complicate the measurement of blood viscosity. It is true that in a steady state flow of a viscous fluid through a rigid spherical body immersed in the fluid, where we assume the inertia is negligible in such a flow, it is believed that the downward gravitational force of the particle is balanced by the viscous drag force. From this force balance the speed of fall can be shown to be given by Stokes' law
Where a is the particle radius, ρp, ρf are the respectively particle and fluid density μ is the fluid viscosity, g is the gravitational acceleration. From the above equation we can see that the sedimentation velocity of the particle depends on the square of the radius. If the particle is released from rest in the fluid, its sedimentation velocity Us increases until it attains the steady value called the terminal velocity (U), as shown above.
We have looked at blood flow and blood composition. Before we look at the main issue, hemodilution, let us take a brief history into the use of blood. Its therapeutic use is not a modern phenomenon. Egyptian writings dates back at least 2000 years suggest oral ingestion of blood as a ‘sovereign remedy’ for leprosy. Experiments with the first intravenous blood transfusions began at the start of the 16th century, and in the last 50 years the field of transfusion medicine has progressed remarkably, bringing with it an increase in the use of blood and blood products. However, the therapeutic use of blood comes with significant risks. As a result, many persons are searching for alternatives to the transfusion of whole blood. Today, bloodless medicine and surgery (BMS) programs have been developed not only for people with certain religious beliefs, but also for patients who fear the risks of blood transfusions and desire to take the best possible medical precautions.
Hemodilution is the dilution of the concentration of red blood cells and plasma constituents by partially substituting the blood with colloids or crystalloids. It is a strategy to avoid exposure of patients to the hazards of homologous blood transfusions.
Hemodilution can be normovolemic which, as we said, implies the dilution of normal blood constituents by the use of expanders. During acute normovolemic hemodilution, (ANH) blood subsequently lost during surgery contains proportionally fewer red blood cells per millimetre, thus minimizing intraoperative loss of the whole blood. Therefore, blood lost by the patient during surgery is not actually lost by the patient, for this volume is purified and redirected into the patient.
There is however hypervolemic hemodilution (HVH). Here, instead of simultaneously exchanging the patient’s blood as in ANH, the hypervolemic technique is carried out by using acute preoperative volume expansion without any blood removal. In choosing a fluid, however, it must be assured that when mixed the remaining blood behaves in the microcirculation as in the original blood fluid, retaining all its properties of viscosity.
In presenting what volume of ANH should be applied one study suggests a mathematical model of ANH which calculates the maximum possible RCM savings using ANH, given the patients weight Hi and Hm. (See below for a glossary of the terms used.)
To maintain the normovolemia, the withdrawal of autologous blood must be simultaneously replaced by a suitable hemodilute. Ideally, this is achieved by isovolemia exchange transfusion of a plasma substitute with a colloid osmotic pressure (OP). A colloid is a fluid containing particles that are large enough to exert an oncotic pressure across the micro-vascular membrane. When debating the use of colloid or crystalloid, it is imperative to think about all the components of the starling equation:
To identify the minimum safe hematocrit desirable for a given patient the following equation is useful:
where EBV is the estimated blood volume; 70 mL/kg was used in this model and Hi (initial hematocrit) is the patient’s initial hematocrit. From the equation above it is clear that the volume of blood removed during the ANH to the Hm is the same as the BLs. How much blood is to be removed is usually based on the weight, not the volume. The number of units that need to be removed to hemodilute to the maximum safe hematocrit (ANH) can be found by
This is based on the assumption that each unit removed by hemodilution has a volume of 450 mL (the actual volume of a unit will vary somewhat since completion of collection ais dependent on weight and not volume). The model assumes that the hemodilute value is equal to the Hm prior to surgery, therefore, the re-transfusion of blood obtained by hemodilution must begin when SBL begins. The RCM available for retransfusion after ANH (RCMm) can be calculated from the patient's Hi and the final hematocrit after hemodilution(Hm)
The maximum SBL that is possible when ANH is used without falling below Hm(BLH) is found by assuming that all the blood removed during ANH is returned to the patient at a rate sufficient to maintain the hematocrit at the minimum safe level
If ANH is used as long as SBL does not exceed BLH there will not be any need for blood transfusion. We can conclude from the foregoing that H should therefore not exceed s. The difference between the BLH and the BLs therefore is the incremental surgical blood loss (BLi) possible when using ANH.
When expressed in terms of the RCM
Where RCMi is the red cell mass that would have to be administered using homologous blood to maintain the Hm if ANH is not used and blood loss equals BLH.
The model used assumes ANH used for a 70 kg patient with an estimated blood volume of 70 ml/kg (4900 ml). A range of Hi and Hm was evaluated to understand conditions where hemodilution is necessary to benefit the patient.
The result of the model calculations are presented in a table given in the appendix for a range of Hi from 0.30 to 0.50 with ANH performed to minimum hematocrits from 0.30 to 0.15. Given a Hi of 0.40, if the Hm is assumed to be 0.25.then from the equation above the RCM count is still high and ANH is not necessary, if BLs does not exceed 2303 ml, since the hemotocrit will not fall below Hm, although five units of blood must be removed during hemodilution. Under these conditions, to achieve the maximum benefit from the technique if ANH is used, no homologous blood will be required to maintain the Hm if blood loss does not exceed 2940 ml. In such a case ANH can save a maximum of 1.1 packed red blood cell unit equivalent, and homologous blood transfusion is necessary to maintain Hm, even if ANH is used. This model can be used to identify when ANH may be used for a given patient and the degree of ANH necessary to maximize that benefit.
For example, if Hi is 0.30 or less it is not possible to save a red cell mass equivalent to two units of homologous PRBC even if the patient is hemodiluted to an Hm of 0.15. That is because from the RCM equation the patient RCM falls short from the equation giving above. If Hi is 0.40 one must remove at least 7.5 units of blood during ANH, resulting in an Hm of 0.20 to save two units equivalence. Clearly, the greater the Hi and the greater the number of units removed during hemodilution, the more effective ANH is for preventing homologous blood transfusion. The model here is designed to allow doctors to determine where ANH may be beneficial for a patient based on their knowledge of the Hi, the potential for SBL, and an estimate of the Hm. Though the model used a 70 kg patient, the result can be applied to any patient. To apply these result to any body weight, any of the values BLs, BLH and ANHH or PRBC given in the table need to be multiplied by the factor we will call T
Basically, the model considered above is designed to predict the maximum RCM that can save ANH.
In summary, the efficacy of ANH has been described mathematically by means of measurements of surgical blood loss and blood volume flow measurement. This form of analysis permits accurate estimation of the potential efficiency of the techniques and shows the application of measurement in the medical field.
The heart is the driver of the circulatory system, pumping blood through rhythmic contraction and relaxation. The rate of blood flow out of the heart (often expressed in L/min) is known as the cardiac output (CO).
Blood being pumped out of the heart first enters the aorta, the largest artery of the body. It then proceeds to divide into smaller and smaller arteries, then into arterioles, and eventually capillaries, where oxygen transfer occurs. The capillaries connect to venules, and the blood then travels back through the network of veins to the right heart. The micro-circulation — the arterioles, capillaries, and venules —constitutes most of the area of the vascular system and is the site of the transfer of O2, glucose, and enzyme substrates into the cells. The venous system returns the de-oxygenated blood to the right heart where it is pumped into the lungs to become oxygenated and CO2 and other gaseous wastes exchanged and expelled during breathing. Blood then returns to the left side of the heart where it begins the process again.
In a normal circulatory system, the volume of blood returning to the heart each minute is approximately equal to the volume that is pumped out each minute (the cardiac output). Because of this, the velocity of blood flow across each level of the circulatory system is primarily determined by the total cross-sectional area of that level. This is mathematically expressed by the following equation:
- v = Q/A
- v = velocity (cm/s)
- Q = blood flow (ml/s)
- A = cross sectional area (cm2)
Blood flow is also affected by the smoothness of the vessels, resulting in either turbulent (chaotic) or laminar (smooth) flow. Smoothness is reduced by the buildup of fatty deposits on the arterial walls.
The Reynold’s number (denoted NR or Re) is a relationship that helps determine the behavior of a fluid in a tube, in this case blood in the vessel.
The equation for this dimensionless relationship is written as:
- ρ: density of the blood
- v: mean velocity of the blood
- L: characteristic dimension of the vessel, in this case diameter
- μ: viscosity of blood
The Reynold’s number is directly proportional to the velocity and diameter of the tube. Note that NR is directly proportional to the mean velocity as well as the diameter. A Reynold’s number of less than 2300 is laminar fluid flow, which is characterized by constant flow motion, whereas a value of over 4000, is represented as turbulent flow. Due to its smaller radius and lowest velocity compared to other vessels, the Reynold’s number at the capillaries is very low, resulting in laminar instead of turbulent flow.
Often expressed in cm/s. This value is inversely related to the total cross-sectional area of the blood vessel and also differs per cross-section, because in normal condition the blood flow has laminar characteristics. For this reason, the blood flow velocity is the fastest in the middle of the vessel and slowest at the vessel wall. In most cases, the mean velocity is used. There are many ways to measure blood flow velocity, like videocapillary microscoping with frame-to-frame analysis, or laser Doppler anemometry. Blood velocities in arteries are higher during systole than during diastole. One parameter to quantify this difference is the pulsatility index (PI), which is equal to the difference between the peak systolic velocity and the minimum diastolic velocity divided by the mean velocity during the cardiac cycle. This value decreases with distance from the heart.
|Type of blood vessels||Total cross-section area||Blood velocity in cm/s|
|Aorta||3–5 cm2||40 cm/s|
|Capillaries||4500–6000 cm2||0.03 cm/s|
|Vena cavae inferior and superior||14 cm2||15 cm/s|
Resistance is also related to vessel radius, vessel length, and blood viscosity.
- ∆P: pressure drop/gradient
- µ: viscosity
- l: length of tube. In the case of vessels with infinitely long lengths, l is replaced with diameter of the vessel.
- Q: flow rate of the blood in the vessel
- r: radius of the vessel
In a second approach, more realistic of the vascular resistance and coming from experimental observations on blood flows, according to Thurston, there is a plasma release-cell layering at the walls surrounding a plugged flow. It is a fluid layer in which at a distance δ, viscosity η is a function of δ written as η(δ), and these surrounding layers do not meet at the vessel centre in real blood flow. Instead, there is the plugged flow which is hyperviscous because holding high concentration of RBCs. Thurston assembled this layer to the flow resistance to describe blood flow by means of a viscosity η(δ) and thickness δ from the wall layer.
The blood resistance law appears as R adapted to blood flow profile :
- R = resistance to blood flow
- c = constant coefficient of flow
- L = length of the vessel
- η(δ) = viscosity of blood in the wall plasma release-cell layering
- r = radius of the blood vessel
- δ = distance in the plasma release-cell layer
Blood resistance varies depending on blood viscosity and its plugged flow (or sheath flow since they are complementary across the vessel section) size as well, and on the size of the vessels. Assuming steady, laminar flow in the vessel, the blood vessels behavior is similar to that of a pipe. For instance if p1 and p2 are pressures are at the ends of the tube, the pressure drop/gradient is:
The larger arteries, including all large enough to see without magnification, are conduits with low vascular resistance (assuming no advanced atherosclerotic changes) with high flow rates that generate only small drops in pressure. The smaller arteries and arterioles have higher resistance, and confer the main blood pressure drop across major arteries to capillaries in the circulatory system.
In the arterioles blood pressure is lower than in the major arteries. This is due to bifurcations, which cause a drop in pressure. The more bifurcations, the higher the total cross-sectional area, therefore the pressure across the surface drops. This is why the arterioles have the highest pressure-drop. The pressure drop of the arterioles is the product of flow rate and resistance: ∆P=Q xresistance. The high resistance observed in the arterioles, which factor largely in the ∆P is a result of a smaller radius of about 30 µm. The smaller the radius of a tube, the larger the resistance to fluid flow.
Immediately following the arterioles are the capillaries. Following the logic observed in the arterioles, we expect the blood pressure to be lower in the capillaries compared to the arterioles. Since pressure is a function of force per unit area, (P = F/A), the larger the surface area, the lesser the pressure when an external force acts on it. Though the radii of the capillaries are very small, the network of capillaries have the largest surface area in the vascular network. They are known to have the largest surface area (485 mm) in the human vascular network. The larger the total cross-sectional area, the lower the mean velocity as well as the pressure.
Substances called vasoconstrictors can reduce the size of blood vessels, thereby increasing blood pressure. Vasodilators (such as nitroglycerin) increase the size of blood vessels, thereby decreasing arterial pressure.
If the blood viscosity increases (gets thicker), the result is an increase in arterial pressure. Certain medical conditions can change the viscosity of the blood. For instance, anemia (low red blood cell concentration), reduces viscosity, whereas increased red blood cell concentration increases viscosity. It had been thought that aspirin and related "blood thinner" drugs decreased the viscosity of blood, but instead studies found that they act by reducing the tendency of the blood to clot.
Regardless of site, blood pressure is related to the wall tension of the vessel according to the Young–Laplace equation (assuming that the thickness of the vessel wall is very small as compared to the diameter of the lumen):
- P is the blood pressure
- t is the wall thickness
- r is the inside radius of the cylinder.
- is the cylinder stress or "hoop stress".
For the thin-walled assumption to be valid the vessel must have a wall thickness of no more than about one-tenth (often cited as one twentieth) of its radius.
- F is the force exerted circumferentially on an area of the cylinder wall that has the following two lengths as sides:
- t is the radial thickness of the cylinder
- l is the axial length of the cylinder
When force is applied to a material it starts to deform or move. As the force needed to deform a material (e.g. to make a fluid flow) increases with the size of the surface of the material A., the magnitude of this force F is proportional to the area A of the portion of the surface. Therefore, the quantity (F/A) that is the force per unit area is called the stress. The shear stress at the wall that is associated with blood flow through an artery depends on the artery size and geometry and can range between 0.5 and 4 Pa.
Under normal conditions, to avoid atherogenesis, thrombosis, smooth muscle proliferation and endothelial apoptosis, shear stress maintains its magnitude and direction within an acceptable range. In some cases occurring due to blood hammer, shear stress reaches larger values. While the direction of the stress may also change by the reverse flow, depending on the hemodynamic conditions. Therefore, this situation can lead to atherosclerosis disease.
Veins are described as the "capacitance vessels" of the body because over 70% of the blood volume resides in the venous system. Veins are more compliant than arteries and expand to accommodate changing volume.
The blood pressure in the circulation is principally due to the pumping action of the heart. The pumping action of the heart generates pulsatile blood flow, which is conducted into the arteries, across the micro-circulation and eventually, back via the venous system to the heart. During each heartbeat, systemic arterial blood pressure varies between a maximum (systolic) and a minimum (diastolic) pressure. In physiology, these are often simplified into one value, the mean arterial pressure (MAP), which is calculated as follows:
- MAP ≈ 2⁄3(BPdia) + 1⁄3(BPsys)
- MAP = Mean Arterial Pressure
- BPdia = Diastolic blood pressure
- BPsys = Systolic blood pressure
Differences in mean blood pressure are responsible for blood flow from one location to another in the circulation. The rate of mean blood flow depends on both blood pressure and the resistance to flow presented by the blood vessels. Mean blood pressure decreases as the circulating blood moves away from the heart through arteries and capillaries due to viscous losses of energy. Mean blood pressure drops over the whole circulation, although most of the fall occurs along the small arteries and arterioles. Gravity affects blood pressure via hydrostatic forces (e.g., during standing), and valves in veins, breathing, and pumping from contraction of skeletal muscles also influence blood pressure in veins.
The relationship between pressure, flow, and resistance is expressed in the following equation:
- Flow = Pressure/Resistance
When applied to the circulatory system, we get:
- CO = (MAP – RAP)/TPR
- CO = cardiac output (in L/min)
- MAP = mean arterial pressure (in mmHg), the average pressure of blood as it leaves the heart
- RAP = right atrial pressure (in mmHg), the average pressure of blood as it returns to the heart
- TPR = total peripheral resistance (in mmHg * min/L)
A simplified form of this equation assumes right atrial pressure is approximately 0:
- CO ≈ MAP/TPR
The ideal blood pressure in the brachial artery, where standard blood pressure cuffs measure pressure, is <120/80 mmHg. Other major arteries have similar levels of blood pressure recordings indicating very low disparities among major arteries. In the innominate artery, the average reading is 110/70 mmHg, the right subclavian artery averages 120/80 and the abdominal aorta is 110/70 mmHg. The relatively uniform pressure in the arteries indicate that these blood vessels act as a pressure reservoir for fluids that are transported within them.
Pressure drops gradually as blood flows from the major arteries, through the arterioles, the capillaries until blood is pushed up back into the heart via the venules, the veins through the vena cava with the help of the muscles. At any given pressure drop, the flow rate is determined by the resistance to the blood flow. In the arteries, with the absence of diseases, there is very little or no resistance to blood. The vessel diameter is the most principal determinant to control resistance. Compared to other smaller vessels in the body, the artery has a much bigger diameter (4 mm), therefore the resistance is low.
The arm–leg (blood pressure) gradient is the difference between the blood pressure measured in the arms and that measured in the legs. It is normally less than 10 mm Hg, but may be increased in e.g. coarctation of the aorta.
Hemodynamic monitoring is the observation of hemodynamic parameters over time, such as blood pressure and heart rate. Blood pressure can be monitored either invasively through an inserted blood pressure transducer assembly (providing continuous monitoring), or noninvasively by repeatedly measuring the blood pressure with an inflatable blood pressure cuff.
- Acute Normovolemic Hemodilution
- Number of Units During ANH
- Maximum Blood Loss Possible When ANH Is Used Before Homologous Blood Transfusion Is Needed
- Incremental Blood Loss Possible with ANH.(BLH – BLs)
- Maximum blood loss without ANH before homologous blood transfusion is required
- Estimated Blood Volume(70 mL/kg)
- Haematocrit Always Expressed Here As A Fraction
- Initial Haematocrit
- Minimum Safe Haematocrit
- Packed Red Blood Cell Equivalent Saved by ANH
- Red cell mass.
- Cell Mass Available For Transfusion after ANH
- Red Cell Mass Saved by ANH
- Surgical Blood Loss
Etymology and pronunciationEdit
Notes and referencesEdit
- Tortora, Gerard J.; Derrickson, Bryan (2012). "The Cardiovascular System: The Blood". Principles of Anatomy & Physiology (13th ed.). John Wiley & Sons. pp. 729–732. ISBN 978-0-470-56510-0.
- Fieldman, Joel S.; Phong, Duong H.; Saint-Aubin, Yvan; Vinet, Luc (2007). "Rheology". Biology and Mechanics of Blood Flows, Part II: Mechanics and Medical Aspects. Springer. pp. 119–123. ISBN 978-0-387-74848-1.
- Rand, Peter (31 May 1963). "Human blood under normothermic and hypothermic conditions" (PDF). Journal of Applied Physiology. Retrieved 16 September 2014.
- Caro, C.G.; Pedley, T.J.; Schroter, R.C.; Seed, W.A. (1978). The Mechanics of Circulation. Oxford University Press. pp. 3–60, 151–176. ISBN 0-19-263323-6.
- "Bloodless medicine and surgery". Retrieved 5 April 2011.
- "Efficacy of Acute Normovolemic hemodilution, Accessed as a Function of Blood lost". the journal of American society of anesthsiologist inc. Retrieved 5 April 2011.
- "Hemodilution:Modelling and clinincal Aspects". IEEE. Retrieved 5 April 2011.
- "maximum blood savings by acute Normovolemic hemodilution". anesthesia & analgesia the gold standard in anesthesiology. Retrieved 5 April 2011.
- Costanzo, Linda S. (2003). Physiology. Board Review Series (3rd ed.). Philadelphia: Lippincott Williams and Wilkins. pp. 73–113. ISBN 0781739195.
- Munson BR, Young DF, Okiishi TH, Huebsch WW (2009). Fundamentals of Fluid Mechanics (Sixth ed.). New Jersey: John Wiley &Sons, Inc. p. 725. ISBN 978-0-470-26284-9.
- Fung, Yuan-cheng; Zweifach, B.W. (1971). "Microcirculation: Mechanics of Blood Flow in Capillaries". Annual Review of Fluid Mechanics. 3: 189–210. Bibcode:1971AnRFM...3..189F. doi:10.1146/annurev.fl.03.010171.001201.
- Tortora, Gerard J.; Derrickson, Bryan (2012). "The Cardiovascular System: Blood Vessels and Hemodynamics". Principles of Anatomy & Physiology (13th ed.). John Wiley & Sons. p. 816. ISBN 978-0470-56510-0.
- Stücker, M.; Bailer, V.; Reuther, T.; Hoffman, K.; Kellam, K.; Altmeyer, P. (1996). "Capillary Blood Cell Velocity in Human Skin Capillaries Located Perpendicularly to the Skin Surface: Measured by a New Laser Doppler Anemometer". Microvasc Research. 52 (2): 188–192. doi:10.1006/mvre.1996.0054. PMID 8901447.
- Tortora, Gerard J.; Derrickson, Bryan (2012). "The Cardiovascular System: Blood Vessels and Hemodynamics". Principles of Anatomy & Physiology (13th ed.). John Wiley & Sons. "Laminar flow analysis". p. 817. ISBN 978-0470-56510-0.
- Marieb, Elaine N.; Hoehn, Katja (2013). "The Cardiovascular System:Blood Vessels". Human anatomy & physiology (9th ed.). Pearson Education. p. 712. ISBN 978-0-321-74326-8.
- GB Thurston, Viscosity and viscoelasticity of blood in small diameter tubes, Microvasular Research 11, 133 146, 1976
- Womersley JR (1955). "Method for the calculation of velocity, rate of flow and viscous drag in arteries when the pressure gradient is known". Journal of Physiology. 127 (3): 553–63. PMC . PMID 14368548.
- Sircar, Sabyasach (2008). Principles of Medical Physiology. India: vistasta Publishing. ISBN 978-1-58890-572-7.
- Fung, Yuan-cheng (1997). Biomechanics:Circulation. New York: Springer. p. 571. ISBN 0-387-94384-6.
- Rosenson RS, Wolff D, Green D, Boss AH, Kensey KR (February 2004). "Aspirin. Aspirin does not alter native blood viscosity". J. Thromb. Haemost. 2 (2): 340–1. doi:10.1111/j.1538-79333.2004.0615f.x. PMID 14996003.
- Potters (13 February 2014). "Measuring Wall Shear Stress Using Velocity-Encoded MRI". Current Cardiovascular Imaging Reports. 7. doi:10.1007/s12410-014-9257-1. Retrieved 16 September 2014.
- Tazraei, P.; Riasi, A.; Takabi, B. (2015). "The influence of the non-Newtonian properties of blood on blood-hammer through the posterior cerebral artery". Mathematical biosciences. 264: 119–127. doi:10.1016/j.mbs.2015.03.013.
- Lough, Mary (2015-04-15). Hemodynamic Monitoring: Evolving technologies and clinical practice (1 ed.). St. Louis, Missouri: Elsevier Mosby. p. 25. ISBN 978-0-323-08512-0.
- Caro, Colin G. (1978). The Mechanics of The Circulation. Oxford [Oxfordshire]: Oxford University Press. ISBN 0-19-263323-6.
- "Normal Blood Pressure Range Adults". Health and Life.
- Klabunde, Richard (2005). Cardiovascular Physiology Concepts. Lippincott Williams & Wilkins. pp. 93–4. ISBN 978-0-7817-5030-1.
- Markham LW, Knecht SK, Daniels SR, Mays WA, Khoury PR, Knilans TK (November 2004). "Development of exercise-induced arm-leg blood pressure gradient and abnormal arterial compliance in patients with repaired coarctation of the aorta". Am. J. Cardiol. 94 (9): 1200–2. doi:10.1016/j.amjcard.2004.07.097. PMID 15518624.
- "haemodynamic". Oxford Dictionaries. Oxford University Press. Retrieved 2016-01-20.
- Berne RM, Levy MN. Cardiovascular physiology. 7th Ed Mosby 1997
- Rowell LB. Human Cardiovascular Control. Oxford University press 1993
- Braunwald E (Editor). Heart Disease: A Textbook of Cardiovascular Medicine. 5th Ed. W.B.Saunders 1997
- Siderman S, Beyar R, Kleber AG. Cardiac Electrophysiology, Circulation and Transport. Kluwer Academic Publishers 1991
- American Heart Association
- Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for Quantification of Doppler Echocardiography: A Report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-184
- Peterson LH, The Dynamics of Pulsatile Blood Flow, Circ. Res. 1954;2;127-139
- Hemodynamic Monitoring, Bigatello LM, George E., Minerva Anestesiol, 2002 Apr;68(4):219-25
- Claude Franceschi; Paolo Zamboni Principles of Venous Hemodynamics Nova Science Publishers 2009-01 ISBN Nr 1606924850/9781606924853
- WR Milnor: Hemodynamics, Williams & Wilkins, 1982
- B Bo Sramek: Systemic Hemodynamics and Hemodynamic Management, 4th Edition, ESBN 1-59196-046-0